## Answer
(model generated chain of thought explanation)

Given the patient's presentation, including vague complaints of "achy bones," mild tachycardia, dry mucous membranes, diffuse abdominal pain, and a significantly elevated serum calcium level (15.3 mg/dL), we need to consider several key points:

1. **Metastatic Prostate Cancer**: The patient has known metastatic prostate cancer, which is a common cause of bone pain in advanced cancer patients.

2. **Vague Complaints of "Achy Bones"**: This symptom can be associated with hypercalcemia (elevated calcium levels) due to the release of parathyroid hormone-related protein (PTHrP), which mimics the action of PTH, a hormone that regulates calcium levels in the blood.

3. **Mild Tachycardia and Dry Mucous Membranes**: These findings can be indicative of hypercalcemia, as it can cause an increase in parathyroid hormone secretion, leading to increased bone resorption and subsequent hypercalcemia.

4. **Diffuse Abdominal Pain**: This symptom is nonspecific but can be associated with metastatic disease to the abdominal organs, including the bones.

5. **Elevated Serum Calcium Level (15.3 mg/dL)**: This is a critical finding that points towards hypercalcemia as the underlying cause of the patient's symptoms.

Considering these factors, the best next step in management would be to address the likely cause of the elevated calcium level and its associated symptoms.

- **Option A (Pamidronate)**: This is a bisphosphonate used to treat hypercalcemia by inhibiting bone resorption. It is often the first-line treatment for severe hypercalcemia, especially in patients with known malignancies.
  
- **Option B (Intravenous Normal Saline)**: While hydration is essential, intravenous normal saline alone may not be sufficient to address the underlying cause of hypercalcemia and its symptoms.

- **Option C (Calcitonin)**: This hormone can help lower blood calcium levels but is typically used in acute settings or when there's a specific indication for its use. It's not usually the first-line treatment for chronic hypercalcemia.

- **Option D (Hemodialysis)**: Hemodialysis may be necessary if the patient has severe hypercalcemia and does not respond to medical management, but it is typically reserved for patients with end